[ILS-TH-14] Lunch Seminar 14: Ocular surface damaged by topical anti-glaucoma eye drops
- Apr 03 (Thu)
- 12:15 - 13:15
- Room 19 - Imperial Hotel 2F Botan
- Otsuka Pharmaceutical Co.,Ltd.
- Chair）Tetsuya Yamamoto
- Glaucoma treatment aims to preserve the visual field throughout a person’s lifetime. Therefore, new categories and fixed combinations of drugs have been used in addition to conventional β-blockers, CAIs, and PGs, and their combined therapy has been increased. However, the increased combined therapy of multiple drugs has raised concerns regarding long-term glaucoma treatment, because ingredients in eye drops may damage the ocular surface.Glaucoma and cornea specialists will discuss the optimal usage and combinations of ocular hypotensive medications available in Japan to minimize the incidence of ocular adverse effects and maintain patient comfort.